In the majority of GBM cases, resistance to such genotoxic modalities has been attributed to the attenuation of p53 function by alterations within the p53 signalling axis, including the overexpression of Murine Double Minute-2 (MDM2) [9]–[13]. Here, MDM2 is linked to glioblastoma.